Nuclea Biotechnologies Obtains $5,479,450 New Round

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=cbbc19e2-4540-43bf-a735-333c0d4614bb&Preview=1
Date
11/2/2010
Company Name
Nuclea Biotechnologies
Mailing Address
105 South Street Pittsfield, MA 01201
Company Description
Nuclea Biotechnologies’ primary mission is to conduct genomic research in the oncology field so as to discover biomarkers and gene or protein expression profiles that are unique to oncologic diseases.
Website
http://www.nucleabiomarkers.com
Transaction Type
Venture Equity
Transaction Amount
$5,479,450
Transaction Round
Undisclosed
Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing.
M&A Terms
Venture Investor
Undisclosed